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Posttranslational modifications offer a dynamic way
to regulate protein activity, subcellular localization,
and stability. Here we estimate the effect of phos-
phorylation on protein binding and function for
different types of complexes from human proteome.
We find that phosphorylation sites tend to be located
on binding interfaces in heterooligomeric and weak
transient homooligomeric complexes. Analysis of
molecular mechanisms of phosphorylation shows
that phosphorylation may modulate the strength of
interactions directly on interfaces and that binding
hotspots tend to be phosphorylated in heteroo-
ligomers. Although the majority of complexes do
not show significant estimated stability differences
upon phosphorylation or dephosphorylation, for
about one-third of all complexes it causes relatively
large changes in binding energy. We discuss the
cases where phosphorylation mediates the complex
formation and regulates the function. We show that
phosphorylation sites are more likely to be evolu-
tionary conserved than other interfacial residues.
INTRODUCTION
Cellular regulatory mechanisms provide a sensitive, specific and
robust response to external stimuli and posttranslational modifi-
cations offer a dynamic way to regulate protein activity, subcel-
lular localization, and stability (Olsen et al., 2006; Ptacek and
Snyder, 2006; Schlessinger, 2000). Such dynamic regulation is
achieved through reversibility and fast kinetics of posttransla-
tional modifications, such as when, for example, a phosphate
group can be quickly attached and removed by kinases and
phosphatases, respectively. Indeed, adding or removing a dia-
nionic phosphate group somewhere on a protein might change
its physico-chemical properties, stability, kinetics, and dynamics
(Johnson, 2009). Recent phosphoproteomic analyses have re-
vealed that themajority of proteins in amammalian cell are phos-
phorylated (Olsen et al., 2006; Olsen et al., 2010), so regulatory
mechanisms involving phosphorylation are very widespread.
Many signaling and other types of pathways involve a
dense network of protein-protein interactions, and the reaction
rates of these processes, among other factors, will depend on
protein concentrations and association/dissociation constantsStructure 19, 1807–18of protein assemblies. Phosphorylation can be used to modulate
the nature and the strength of protein-protein interactions,
thereby regulating protein binding and coordinating different
pathways. If phosphorylation occurs at or near a binding inter-
face, it may directly affect the binding energy of the complex.
At the same time, phosphorylation of a site outside a binding
interface may cause long-range conformational changes
through allosteric mechanisms and affect the binding of the
partner, as observed for the classical example of glycogen phos-
phorylase (Jenal and Galperin, 2009; Lin et al., 1997). Another
aspect of coupling between phosphorylation and binding is the
recognition of the phosphates by special phospho-Ser/Thr or
Tyr binding domains (such as 14-3-3, SH2, MH2, and others);
such a process may release the protein from autoinhibition and
result in activation and subsequent signal propagation, as in
the case of Src kinases (Schlessinger, 2000). Finally it has
been shown that flexible regions and intrinsically disordered
proteins have a tendency to be phosphorylated, and phosphor-
ylation might induce disorder-to-order as well as order-to-
disorder transitions (Antz et al., 1999; Collins et al., 2008;
Gsponer et al., 2008; Radhakrishnan et al., 1997).
In this article, we analyze the effect of phosphorylation on
protein binding for different types of complexes from the human
proteome varying by stability and the nature of the interacting
subunits. We show that there exists a coupling between phos-
phorylation and protein-protein binding for all types of heterooli-
gomeric and weak transient homooligomeric complexes.
Computational alanine scanning experiments and analysis of
the energetic effect of attaching/removing phosphate groups
show that phosphorylationmaymodulate the strength of interac-
tions directly on interfaces and that binding hotspots have
a tendency to be phosphorylated for heterooligomers. Although
for many Ser/Thr/Tyr sites we did not find significant stability
differences upon attaching/removing the phosphate group, for
one-third of all complexes this brings about a relatively large
change in binding energy (more than 2 kcal/mol). We analyze
the effect of phosphorylation on protein function and show
that several pathways, especially the hemostasis pathway, are
enriched with phosphoproteins and phosphosites. Finally, we
show that phosphosites on interfaces aremore likely to be evolu-
tionarily conserved than other interfacial residues.
RESULTS
Coupling between Phosphorylation and Protein-Protein
Binding
Using a nonredundant set of 933 structures of phosphory-
lated human hetero- and homooligomeric complexes (see15, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1807
A B Figure 1. Probability Density Function of
the Fraction of Phosphosites in Protein
Complexes and on Binding Interfaces for
Homooligomers and Heterooligomers
Homooligomers (A) had 308 phosphosites in
proteins and 111 on interfaces, and hetero-
oligomers (B) had 290 phosphosites in proteins
and 160 on interfaces. The difference between the
mean values of these distributions is significant
(p value = 2e-16 for both homooligomers and
heterooligomers by Wilcoxon rank-sum test).
Inset: curves for permanent homooligomers are
shown in red, strong transient homooligomers are
shown in orange, and weak transient homo-
oligomers are shown in green. The distributions
are smoothed by the Gaussian kernel density
estimation. See also Tables S1 and S2.
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Phosphorylation in Protein BindingExperimental Procedures for detail), we observed on average
two phosphorylation sites (pTyr, pSer, or pThr) per protein.
Note that the majority of protein complexes do not have actual
phosphate groups in the Protein Data Bank (PDB) structures
(Zanzoni et al., 2011). As one can see from Figure 1, the distribu-
tion of fractions of phosphosites in phosphoproteins is quite
narrow with a large majority of all phosphocomplexes having
about 5%-10% of all Ser, Thr, or Tyr residues phosphorylated.
The distribution has a long tail, however, which is consistent
with the fact that proteins with multiple phosphorylation sites
occur more often than expected by chance, in agreement with
previous studies for Arabidopsis thaliana (Rian˜o-Pacho´n et al.,
2010). Overall, we observed the relative fractions of the types
of phosphosites to be 40% pSer, 25% pThr, and 35%
pTyr in protein structural complexes, and this observation did
not depend on whether the complexes represented hetero- or
homooligomers. The frequencies of pSer, pThr, and pTyr
observed in structural complexes were quite different from those
obtained in high-throughput experiments for phosphopro-
teomes, which identified only a small fraction of pTyr sites
(Hunter and Sefton, 1980; Olsen et al., 2006). This discrepancy
may be explained by the observation that hydrophobic Tyr is
more likely to be found in structured regions, whereas Ser and
Thr are frequently found in disordered and flexible regions.
Indeed, it was reported recently that almost half of pTyr sites
were located within conserved protein domains (Sugiyama
et al., 2008). Moreover, tyrosine phosphorylation might occur
on less abundant proteins compared to serine and threonine
phosphorylation, hence the statistics for rather redundant phos-
phoproteomes may differ from our nonredundant set.
Further, we studied the coupling between phosphorylation
and protein-protein binding by examining binding interfaces
and locations of phosphosites in complexes (see Table S1 avail-
able online). Overall, we found that the association between
phosphorylation sites and binding interfaces is very strong for
heterooligomers (Fisher’s exact test, p value = 7.4e-15) and
significant but not so prominent for weak transient homoo-
ligomers (p value = 0.0008) (Figure 1; Table 1; Table S2). No
association was found for permanent and strong transient
homooligomers. Because the stability of the complex depends
on the number of subunits, we also performed a similar analysis
restricted to dimers and found a similar trend (p value = 5.3e-061808 Structure 19, 1807–1815, December 7, 2011 ª2011 Elsevier Ltdfor heterooligomers). The tendency of phosphosites to be
involved in binding did not correlate with the estimated stability
of heterooligomers, which in turn were generally less stable
than all homoologomers according to our analysis (Wilcoxon
rank-sum test, p value = 0.03). These results are consistent
with our previous study, which showed that transient complexes
that bind different protein partners using the same interface
(promiscuous binding) are enriched with Tyr, Ser, and Thr
(among a few other residues) on their interfaces, and their phos-
phorylation may provide the switch between different functional
pathways (Tyagi et al., 2009).
Structural Environment of Phosphorylation Sites
Although phosphorylation sites are usually located on protein
surfaces, some of their structural properties are different from
the other surface residues (Gnad et al., 2007; Jime´nez et al.,
2007; Zanzoni et al., 2011).We analyzed the structural properties
of phosphosites (sites that can be phosphorylated even if there
is no actual phosphate present in the PDB structure) on
interfaces to see if these properties are different from nonphos-
phorylated Ser/Thr/Tyr sites on interfaces. Phosphosites in
heterooligomers seem to be more solvent accessible than non-
phosphorylation sites in isolated protomers (on average by
23 A˚2; p value = 2.2e-16) and tend to change solvent accessibility
upon complex formation by burying more surface area (on
average by 13A˚2; p value = 2.2e-16, Table 1; Figure S1). This is
consistent with our previous observation that phosphosites are
predominantly located on binding interfaces. At interfaces,
phosphorylation sites contribute to the complex stability by
forming more hydrogen bonds and residue contacts than non-
phosphosites (for hydrogen bond difference, p value = 0.0005
for heterooligomers and p value = 0.04 for weak homooligomers;
Table 1). Additionally, Tyr residues tend to be located in the core
of protein interfaces, playing a critical role for oligomerization
through aromatic stacking interactions, its phosphorylation
therefore might directly affect the binding affinity. The estimate
of binding energy provides additional evidence for these find-
ings, as shown in the following section.
Energetic Effect of Phosphorylation
Residues that are essential for the structural integrity of proteins
or protein complexes are called binding hotspots (Bogan andAll rights reserved
Table 1. Properties of Phosphorylation Sites on Protein Binding Interfaces
All All Heterooligomers All Homooligomers
Homooligomers
Weak Strong Permanent
Abundance on interface 1.5e-13* 7.4e-15* 0.097 8.2e-04* 0.417 0.054
Structural properties
Protomer ASAa 2.2e-16* 2.2e-16* 0.065 0.057 0.318 0.137
DASAb 4.5e-08* 1.7e-09* 0.482 0.609 0.361 0.050
No. of hydrogen bonds per site 5.9e-05* 5.3e-04* 0.043* 0.042* 0.272 0.202
No. of residue-residue contacts per site 2.8e-04* 1.1e-03* 0.217 0.502 0.424 0.452
Energetic propertiesc
DDDGala 1.8e-03* 2.7e-04* 0.494 0.181 0.670 0.390
DDDGp 2.2e-16* 1.3e-12* 1.3e-08* 2.8e-05* 1.1e-04* 1.6e-05*
Evolutionary conservation of site 0.018* 0.016* 0.296 0.558 0.113 0.654
All values are presented as p values. The ‘‘Abundance on interface’’ row presents p values calculated by Fisher’s exact test showing association
between being phosphorylated and location on binding interface (compared to surface). All other rows present p values calculated by Wilcoxon
rank-sum test showing the difference between phosphosites and nonphosphosites on binding interfaces with respect to different properties.
Significant p values (after Holm-Bonferroni correction) showing enrichment of phosphosites with a given property are denoted with an asterisk (*).
ASA, accessible surface area.
a ASA of a given protomer without binding partner.
bDifference in ASA upon complex formation.
cDDDGala is the difference in binding energy upon Ala substitution. DDDGp is the difference in binding energy upon attaching/removing phosphate
groups to phosphorylation sites on interfaces. The p values for DDDGp indicate whether the distribution is significantly shifted to positive values.
See also Figure S1 and S2.
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Phosphorylation in Protein BindingThorn, 1998; Tuncbag et al., 2009). They are predominantly
located on interaction interfaces, and their substitution by
different amino acids (for example, Ala) causes large differences
in binding energy (more than 1-2 kcal/mol), destabilizing
the complex. The effect of such substitutions and therefore
the contribution of a given site to the binding energy can
be measured in terms of DDDGala (see Experimental Proce-
dures). We performed substitutions of Tyr/Thr/Ser residues in
phosphoproteins from our test set by Ala (computational alanine
scanning experiments) and calculated DDDGala separately
for phosphorylation and nonphosphorylation sites using the
FoldX algorithm (see Experimental Procedures). Overall, the
substitution of amino acids at both phosphorylation and non-
phosphorylation sites destabilizes the complex, and theDDDGala
distributions are significantly shifted to positive values for all
homo- and heterooligomeric complexes (p values = 2.2e-16 for
both). We did not detect any Ala substitutions that would result
in increased stability of the native complex by more than
2 kcal/mol (negative values of DDDGala correspond to stabilizing
substitutions). This implies that the interfaces are relatively well
optimized, which is congruent with the previous studies (Brock
et al., 2007).
Even though the majority of substitutions on interfaces do
not change the binding energy very much, a significant fraction
of them (10% for homooligomers and 13% for heteroo-
ligomers) contribute to a DDDGala of more than +2 kcal/mol
(destabilizing the complex); in other words, they form binding
hotspots. We considered whether phosphorylation events
tend to involve binding hotspots. We found that for heteroo-
ligomers, the DDDGala values for amino acid substitutions at
phosphorylation sites on binding interfaces are larger com-
pared to other sites on interfaces (Wilcoxon rank-sum test,
p value = 0.0003); namely, 7% of nonphosphorylation sitesStructure 19, 1807–18and 13% of phosphorylation sites correspondingly contribute
more than 2 kcal/mol to DDDGala (20% of nonphosphorylation
sites and 30% of phosphorylation sites have a DDDGala of
more than 1 kcal/mol). In general, the association between
phosphosites and binding hotspots is statistically significant
for the entire dataset, and for heterooligomers in particular
(Fisher’s exact test, p value = 0.0006).This result does not
hold true if only homooligomers are considered (Table 1;
Figure S2).
As mentioned previously, the majority of protein complexes in
PDB do not have actual phosphate groups present. Therefore, to
further assess the energetic effect of phosphorylation, we
attached the phosphate group to those Ser/Thr/Tyr sites on
binding interfaces that are known to be phosphorylated and
calculated the change of binding energy upon phosphorylation
as DDDGp (see Experimental Procedures). In the majority of
cases, phosphorylation resulted in very moderate changes in
the estimated binding energy of about +0.5-1.5 kcal/mol. Exper-
imental studies on MAPK cascade scaffold protein showed
that introducing phosphate increases the dissociation energy
by about 1.5 kcal/mol (Serber and Ferrell, 2007; Strickfaden
et al., 2007). Nevertheless, overall, the DDDGp distribution
was significantly shifted toward positive values (Figure 2; p value
is 1.3e-08 for homooligomers and 1.3e-12 for heterooligomers).
Namely, in 39% and 35% of the cases, the attachment of a
phosphate group destabilized the complex for hetero- and
homooligomers, respectively, by more than +2 kcal/mol. The
phosphorylation of heterooligomers caused slightly higher
destabilization compared to homooligomers. On the other
hand, there were 8 and 64 cases where phosphorylation resulted
in DDDGp values of less than 2 and -1 kcal/mol, respectively,
leading to complex stabilization. There were 12 complexes in
our test set where the actual phosphate group was resolved on15, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1809
Figure 2. Probability Density Function of the Change in Binding
Energy upon Phosphorylation for Interfacial Ser, Thr, and Tyr
(DDDGp)
Curves for homooligomers (n = 74 phosphosites on interfaces) are shown in
pink; curves for heterooligomers (n = 104) are shown in blue. Note that DDDGp
was calculated only for dimers due to the limitations of the program. The
distribution is shifted toward positive values (p value = 2e-16). Inset: perma-
nent homooligomers are shown in red, strong transient homooligomers are
shown in orange, and weak transient homooligomers are shown in green. The
distributions are smoothed by the Gaussian kernel density estimation.
Structure
Phosphorylation in Protein Bindingprotein interfaces; in these cases, we removed the phosphate
group and assessed the effect, and in most cases the DDDGp
was less than 2 kcal/mol.
Evolutionary Conservation of Phosphosites
The evolutionary conservation of phosphorylation sites has been
a topic of several studies; it has been found that phosphopro-
teins are more conserved in evolution than nonphosphorylated
ones (Boekhorst et al., 2008; Macek et al., 2008), whereas
the conservation of phosphorylation sites is limited (Levy
et al., 2010). One of the reasons for weak conservation of
phosphorylation sites is that the majority of phosphorylation
events might have occurred relatively recently in evolution,
especially Tyr phosphorylation (Chen et al., 2010; Gnad et al.,
2010; Sridhara et al., 2011). In an attempt to clarify this contro-
versy, we mapped phosphorylation sites on multiple sequence
alignments of manually curated Conserved Domain Database
(CDD) families at the superfamily level and calculated their
sequence conservation. Overall, 539 protein complexes from
our dataset were mapped to 292 CDD families. First, we found
in consensus with other studies (Boekhorst et al., 2008; Gnad
et al., 2007; Gray and Kumar, 2011; Zanzoni et al., 2011) that
phosphorylation sites are more conserved than the surface sites
for heterooligomers (Wilcoxon rank-sum test, p value = 0.00001;
Figure S3). Next, we went further and checked whether phos-
phorylation sites on interfaces are more conserved than other
interface sites. Figure 3 shows the probability density plot of1810 Structure 19, 1807–1815, December 7, 2011 ª2011 Elsevier Ltdsequence conservation calculated with respect to background
conservation of the overall family for both phosphosites and all
other Tyr/Thr/Ser sites on interfaces. This figure shows that
heterooligomers, unlike homooligomers, have a small peak in
the positive range of interface conservation values, which is
consistent with previous studies (Choi et al., 2009). Moreover,
the majority of nonphosphorylation sites on interfaces are less
conserved than the family background (the mean value of the
distribution is shifted toward negative values), which can be
explained by the fact that protein core residues and active sites
might be under stronger evolutionary pressure than Ser, Thr, and
Tyr residues on interfaces.
When we look at the conservation of phosphorylaion sites,
it is evident that there are two almost equal populations of
Ser/The/Tyr sites: those that are less conserved than the family
background and those that are more conserved than the back-
ground. Overall, the conservation distribution for phosphosites
is significantly shifted toward positive values compared to
conservation of interfacial nonphosphosites for all complexes,
and for heterooligomers in particular (p value = 0.018 for all;
p value = 0.016 for heterooligomers). When calculated sepa-
rately for homooligomers, this shift is not significant. Thus, we
see that phosphosites are more conserved than nonphospho-
sites on interfaces in human complexes, implying that there is
additional evolutionary pressure to conserve the phosphosites,
which are important for binding events. This is also consistent
with our previous observation that phosphosites in heteroo-
ligomers have a tendency to be located at the binding hot spots,
and such hot spots are more evolutionarily conserved than the
rest of the interface.
Functions of Phosphorylated Complexes
It has been reported that phosphorylated proteins have specific
molecular functions in a cell (Wang et al., 2011). We analyzed our
nonredundant set of homooliogomers and heterooligomers,
including phosphorylated and nonphosphorylated proteins
(see Experimental Procedures), and studied their association
with particular Gene Ontology (GO) protein functions. We
found that heterooligomers with GO annotations ‘‘catalytic’’
(GO: 0003824), ‘‘hydrolase’’ (GO: 0016787), ‘‘transferase’’ (GO:
0016740), and ‘‘signal transducer’’ (GO: 0004871) activities
have larger numbers of phosphorylation sites on interfaces
compared to other proteins (Figure S4; Table S3).
It is also known that some pathways are differentially regulated
by using reversible phosphorylation of their constituent proteins.
In this respect, we performed an analysis of phosphorylated
complexes participating in different biological pathways.
The data on pathways were taken from the National Center
for Biotechnology Information Biosystems database, which
includes 5016 human specific pathways, mostly coming
from KEGG and Reactome sources (Geer et al., 2010). We
found that metabolic and hemostasis pathways (KEGG pathway
ID: hsa01100; Reactome ID: REACT_604) were significantly
enriched with phosphorylated homooligomeric complexes
(p value = 0.002), whereas the ‘‘Hemostasis’’ (REACT_604),
‘‘Pathways in cancer’’ (hsa05200), ‘‘Cell Cycle, Mitotic’’
(REACT_152), and ‘‘Signaling in immune system’’ (REACT_6900)
pathways were enriched with phosphorylated heterooligomeric
complexes (p value = 0.00001; Table S3).All rights reserved
A B Figure 3. Probability Density Function of the
Conservation Score Calculated for Phos-
phorylation Sites on Binding Interfaces
Zero conservation score corresponds to the same
amount of evolutionary conservation as the mean
conservation of the protein family.
(A) For homooligomers, conservation of phos-
phorylation sites (n = 275 phosphosites on inter-
faces) is shown in red and conservation of
nonphosphorylation sites (n = 2773) is shown in
purple.
(B) For heterooligomers, conservation of phos-
phorylation sites (n = 521) is shown in blue
and conservation of nonphosphorylation sites
(n = 5559) is shown in green. The conservation
distribution for phosphosites is significantly
shifted toward positive values compared to con-
servation of interfacial nonphosphosites for all complexes, and for heterooligomers in particular (p value = 0.018 for all and p value = 0.016 for hetero-
oligomers). The distributions are smoothed by the Gaussian kernel density estimation. See also Figure S3.
Figure 4. Phosphorylation in Smad1 and Smad2 Complexes
(A) Superposition of Smad2 structure (PDB ID: 1khx; yellow) and phosphory-
lated model of Smad1 generated by FoldX (based on 1khu; individual subunits
are shown in magenta, green, and blue). Phosphorylated Ser462, Ser463, and
Ser465 are colored in red.
(B) C-terminal loops of three subunits of phosphorylated Smad1 and Smad2.
Colors of the subunits are the same as in (A), and phosphate groups are
depicted in the same color as subunits.
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Phosphorylation in Protein BindingPhosphorylation Mediates Complex Formation:
Smad Proteins
Transforming growth factor-b signaling is controlled by receptor
Ser/Thr kinases and the Smad protein family. In response to
cytokine oligomerization, phosphorylation of Ser residues and
subsequent activation of cytoplasmic Ser/Thr kinase occurs.
Activated kinase then phosphorylates the C-terminal SSXSmotif
of specific tumor suppressors from the R-Smad (Smad1,
Smad2) protein family. Once phosphorylated, the SSXS motif
of Smad2 promotes the formation of a heterooligomer between
R-Smad and Smad4, which in turn regulates gene expression.
We compared a Smad1 protein from our test set (PDB accession
1khu) with a Smad2 protein (1khx) that has actual phosphate
groups present in the crystal structure (except for the first Ser).
Both structures have the SSXS motif located on the binding
interface; moreover, these proteins are 80% identical and
display extensive structural similarity (Figure 4A). We considered
the effect of phosphorylation and dephosphorylation of Smad1
and Smad2 on trimer formation. We made a model of phosphor-
ylated Smad1 and calculated the change in binding energy upon
phosphorylation of Smad1 and also dephosphorylation of
Smad2 (see Experimental Procedures). The model of phosphor-
ylated state of the Smad1 is shown in Figure 4A; the different
subunits are depicted in blue, green, and magenta, whereas
the structure of the actual phosphorylated state of Smad2
protein is depicted in yellow. We showed that phosphorylation
of all Ser, especially the third one in the SSXS motif, stabilized
the complex of Smad1 (negative average DDDGp values up to
1.5 kcal/mol; Table 2). At the same time, dephosphorylation
of the second and especially third Ser destabilized the Smad2
complex by up to 2 kcal/mol. Removing the phosphate group
of the first Ser slightly stabilized the complex.
The results of our computations are consistent with experi-
mental results obtained for the Smad2 protein (Wu et al.,
2001), and the effect of phosphorylation of the first Ser in the
SSXS motif is still considered controversial (Abdollah et al.,
1997). These experimental studies demonstrate that unphos-
phorylated Smad2 exists as a monomer, whereas phosphoryla-
tion of Smad2 promotes homotrimer formation through its
MH2 domain (Wu et al., 2001). Interestingly, the trimer interface
overlaps with the interface for the interaction between theStructure 19, 1807–18Smad2-MH2 domain and receptor Ser/Thr kinase domain, and
aswas shown previously, phosphorylation facilitates the dissoci-
ation of Smad2 from kinase (Wu et al., 2001). Therefore, this
provides an example where phosphorylation mediates the
complex formation and, through competitive binding, imple-
ments a negative control mechanism promoting the dissociation
of the heterologomeric complex of Smad2 with the kinase
domain.
DISCUSSION
We found that the vast majority of phosphocomplexes contain
just a few phosphorylation sites, whereas for some proteins up
to half of their sites (Ser, Thr, and Tyr sites) are potentially phos-
phorylated at some point, which is evident from the long tail of
the probability distribution (Figure 1) for the fraction of phospho-
sites per protein. Several studies previously established that
phosphosites may form clusters along specific regions of
a protein sequence or on a protein surface (Schweiger and Linial,
2010; Yachie et al., 2009). Although the main reasons for these15, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1811
Table 2. Effect of Phosphorylation/Dephosphorylation on




Smad2 (1khx) SSXS S/pS 0.59 0.59 0.59 0.59
SSXS pS/S 0.88 0.88 0.88 0.88
SSXS pS/S 1.53 1.53 2.86 1.97
Smad1 (1khu) SSXS S/pS 2.11 1.58 0.22 0.25
SSXS S/pS 0.9 1.49 1.74 0.38
SSXS S/pS 1.45 1.87 1.08 1.47
Change in binding energy upon phosphorylation/dephosphorylation is
calculated in terms of DDDGp (negative and positive values correspond
to stabilizing and destabilizing effects, respectively).
a Phosphorylated/dephosphorylated positions in the SSXS motif are
shown as boldface underscored characters.
b Because FoldX can only handle dimeric complexes, Smad trimers were
decomposed into the dimers AB, BC, and AC.
c Average of all three pairs of chains.
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Phosphorylation in Protein Bindingfindings remain largely unknown, it was observed that in some
cases the groups of sites can be phosphorylated simultaneously
and cooperatively, leading to certain advantages in terms of
signal amplification and its strength modulation (Park et al.,
2006). In our study, we showed that phosphosites have a
tendency to be located on binding interfaces in protein com-
plexes, and this trend depends on the type of complex. This
might allow better understanding of the regulation of protein
activity through phosphorylation within the framework of protein
binding.
There are several reasons for such coupling between phos-
phorylation and binding. Phosphorylation may modulate the
strength of interactions, bringing about changes in binding
energy that may trigger the transitions between different
conformer and oligomeric states. For the majority of proteins in
our dataset, the phosphorylation did not change the binding
affinity significantly, which is consistent with several experi-
mental studies pointing to the modest effect of phosphorylation
on stability and protein conformation (Murray et al., 1998; Serber
and Ferrell, 2007; Strickfaden et al., 2007). At the same time, in
one-third of our complexes the attachment of a phosphate group
to interfacial Ser/Thr/Tyr sites, which are expected to be
phosphorylated, caused a relatively large change in estimated
binding energy. This in turn could lead to conformational
changes or preclude undesired interactions due to steric
constraints. Moreover, phosphorylation sites on interfaces
significantly overlapped with the binding hot spots in heterooli-
gomeric complexes, and phosphorylation at binding hotspots
could potentially disrupt the complex formation. In addition, we
showed that phospho Ser/Thr/Tyr on interfaces were more
conserved than nonphosphorylated Ser/Thr/Tyr on interfaces.
It should be mentioned that regulatory mechanisms of phos-
phorylation are quite diverse, and in some cases, phosphoryla-
tion might destabilize the complex and lead to protein activation
or inactivation, whereas in others it maymediate complex forma-
tion and through competitive binding provide a negative control
mechanism (as was shown in the Smad example). In our study,
the phosphate group was attached to only one site at a time,1812 Structure 19, 1807–1815, December 7, 2011 ª2011 Elsevier Ltdand since there can be several phosphosites per protein (on
average there are about two phosphosites per protein in the
set), we expect a greater effect if multiple sites are phosphory-
lated simultaneously.
Phosphorylation might not affect significantly complex
stability, but rather provide diversity in recognition patterns and
offer recognition sites for binding of certain domains and motifs
(e.g., pTyr-binding by the SH2 domain, pSer/pThr binding by
the MH2 and FHA domains), thereby modulating binding selec-
tivity. Indeed, the reversibility of phosphorylation events allows
decoupling of the binding specificity and affinity, thereby medi-
ating specific binding even between proteins within transient
and not very stable complexes. At the same time, phosphoryla-
tion of multiple sites on interfaces may amplify this signal and
provide enhanced binding selectivity. Indeed, such specific
and reversible signaling at the residue level is a good indicator
that a previous stage in cellular signaling networks has been
completed successfully. Many cellular control mechanisms
operate at the level of protein-protein interactions, and main
signaling pathways involve dense networks of protein-protein
interactions and phosphorylation events. Moreover, signaling
pathways are quite often disrupted in cancer, and it was recently
shown that somatic cancer mutations are enriched with those
that cause gain or loss of phosphorylation sites (Radivojac
et al., 2008). Similarly, our study showed that the signaling
pathways ‘‘Hemostasis,’’ ‘‘Pathways in cancer,’’ ‘‘Cell Cycle,
Mitotic,’’ and ‘‘Signaling in immune system’’ are enriched with
phosphorylated heterooligomeric complexes.
Interestingly, we found that metabolic and hemostasis path-
ways are also enriched with phosphorylated homooligomeric
complexes, and phosphosites in weak transient homooligomers
are considerably involved in binding. Previously, we manually
compiled a set of experiments that furnish evidence that phos-
phorylation at or near the homooligomer interface shifted the
equilibrium between different oligomeric states with different
protein activities (Hashimoto et al., 2011). According to the
classical model by Goldbeter and Koshland (1981), posttransla-
tional modifications may allow large activity changes with only
moderate concentration changes to provide sensitive response
to external stimuli. To supplement this model, our analysis offers
additional new evidence for how reversible phosphorylation
events may modulate reversible transitions between different
discrete conformations or oligomeric states in homooligomeric
and heterooligomeric complexes and might represent an impor-
tant mechanism for regulation of protein activity.
EXPERIMENTAL PROCEDURES
Data Set of Phosphorylation Sites
The data on phosphorylation sites in human proteins is derived from the
PhosphoSitePlus (Hornbeck et al., 2004), Phospho.ELM (Dinkel et al., 2011),
and PHOSIDA (Gnad et al., 2007) databases. Most phosphorylation sites in
these databases are identified by high-throughput (HTP) methods that might
contain significant experimental errors (Lin et al., 2010). Therefore, we used
the GPS 2.1 program (Xue et al., 2008) to verify HTP phosphosites. GPS
predicts phosphorylation sites from protein sequence based on sequence
patterns using decision trees. In our study, we employed the most conserva-
tive thresholds reported by GPS with the estimated false-positive rates being
2% and 4% for the Ser/Thr and Tyr sites, respectively. The sites identified by
low-throughput methods (indicated as ‘‘PUBMED_LTP’’ in PhosphoSitePlus
and ‘‘LTP’’ in Phospho.ELM) and HTP sites verified by GPS were then usedAll rights reserved
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to their structures via Uniprot (Magrane and Consortium, 2011), and the
phosphorylation sites were mapped onto PDB structures using the
Muscle alignment algorithm (Edgar, 2004). A protein list with phosphosites
and all results is available at ftp://ftp.ncbi.nih.gov/pub/mmdb/phospho/
phosphorylation_on_complexes.xls.Data Set of Phosphorylated Protein Complexes
We started our analysis with the whole set of PDB structures (Berman et al.,
2000) and retrieved all structures containing more than one protein chain.
The oligomeric states and binding interfaces were defined using the Protein
Interfaces, Surfaces and Assemblies (PISA) algorithm (Krissinel and Henrick,
2007). PISA is considered a standard, state-of-the-art method that detects
biological macromolecular assemblies in PDB with 80%-90% accuracy. We
regard a complex as stable if PISA reports a unique oligomeric state for a given
structure. A complex is considered homooligomeric if sequence identities
between all chain pairs in the complex are more than 90% identity, otherwise
it is defined as heterooligomeric. Phosphorylation sites were mapped to
protein complexes, and then to compile a nonredundant set, similar proteins
(with BLAST, p value < 10e-07) were removed. Finally, we obtained a nonre-
dundant set of 382 homooligomers and 551 heterooligomers with 1983 phos-
phorylation sites altogether. Homooligomers were further divided into three
categories similar to the classification introduced recently by Perkins et al.
(2010). According to their DG of dissociation calculated by PISA, we distin-
guished the following categories: weak transient (DGdiss 0, coexistence of
different oligomeric states), strong transient (0% DGdiss% 20 kcal/mol), and
permanent (DGdiss > 20 kcal/mol) homooligomers. For reference, for dimers
in equilibrium, the concentrations of dimers and monomers are equal at DGdiss
4 kcal/mol (Krissinel and Henrick, 2007).Calculation of Binding Energies
The change in the standard free energy upon complex dissociation may be
calculated as follows:
DG0diss =  RT logKD =  RT log
pni ½Mi 
½C (1)
whereKD is the dissociation constant and [M] and [C] are equilibrium standard-
state concentrations of complexC andmonomersM. Dissociation energy was
calculated with PISA and was used to assess the complex stability. Since
amino acid substitution and phosphate attachment/removal can affect the
stability of both monomers and complexes, we also estimated the binding
energy with the rigid body approach using the same atomic coordinates for
the monomers as in the complexes:
DDGbind =DGC  Sni DGMi (2)
where DGC and DGM are stabilities (unfolding free energies) of the complex
and monomers, respectively.
The computational alanine scanning and attachment/removal of phosphate
groups was performed by the FoldX program (Guerois et al., 2002; Sanchez
et al., 2008) using the ‘‘complex_alascan’’ and ‘‘PositionScan’’ options,
respectively. The FoldX program calculates the stability of protein complexes
using an empirical force field. As was shown previously, FoldX is among
the best three methods used to estimate the effect of mutations on protein
stability. It reaches 0.64 sensitivity and 0.43 specificity (Khan and Vihinen,
2010) of prediction and reports a correlation coefficient between experimental
and computed DDDG values in the range of 0.5-0.8 (Guerois et al.,
2002; Potapov et al., 2009), with the SD of computed DDG values being
0.8 kcal/mol (Guerois et al., 2002). In ‘‘complex alascan’’ mode, FoldX replaces
the residue on the interface by alanine, optimizes their side chain conforma-
tions, and calculates the difference in binding energies between the original
and substituted complexes (DDDGala). Similarly, in ‘‘PositionScan’’ mode,
FoldX attaches/removes a phosphate group to/from Ser/Thr/Tyr, optimizes
the side chain conformations, and calculates the difference in binding energies
between the original and phosphorylated complexes (DDDGp). Positive and
negative values of DDDG correspond to destabilizing and stabilizing effects,
respectively. Note that DDDGp was calculated only for dimers due to limita-
tions of the program.Structure 19, 1807–18Analysis of Evolutionary Conservation of Phosphorylation Sites
To examine the evolutionary conservation of phosphorylation sites, we
searched protein sequences from our data set using RPS-BLAST (Marchler-
Bauer et al., 2002) and the CDD (Marchler-Bauer et al., 2009) and
then embedded the protein sequences in the CDD multiple sequence
alignments. The conservation score was calculated using the al2co program
(Pei and Grishin, 2001) with default parameters. It represented the entropy-
based measure calculated from sequence weighted observed amino acid
frequencies. The score was normalized by subtracting the mean and dividing
by the SD of the score distribution for the whole alignment. Therefore,
the conservation score of a given site can be negative if the site is less
conserved than the average conservation background of protein family, and
vice versa.
Annotating Protein Function and Functional Pathways
We used GO (Ashburner et al., 2000) for the annotation of the protein function.
The ‘‘molecular function’’ terms of each protein were obtained from Gene
Ontology Annotation database (Barrell et al., 2009). For pathway analysis,
we used the NCBI BioSystems Database (Geer et al., 2010) and Flink web
service (http://www.ncbi.nlm.nih.gov/Structure/flink/flink.cgi) to map proteins
to biological pathways. The content of the Biosystems Database comes from
several pathway databases: KEGG (Kanehisa et al., 2010), BioCyc (Caspi
et al., 2010), PID (Schaefer et al., 2009), and Reactome (Croft et al., 2011).
Only human-specific pathways were considered for our analysis. In addition
to the set of phosphorylated protein complexes described above, nonredun-
dant sets of homooligomers and heterooligomers, including phosphorylated
and nonphosphorylated proteins, were compiled to estimate whether phos-
phorylated proteins were enriched in specific function or pathways. All human
complexes were taken from PDB and validated with PISA, and similar proteins
(with BLAST p value < 10e-07) were then removed as described previously.
The final data set contained 248 phosphorylated and 451 nonphosphorylated
homooligomers and 253 phosphorylated and 401 nonphosphorylated heteoo-
ligomers, respectively.SUPPLEMENTAL INFORMATION
Supplemental information includes four figures and three tables and can be
found with this article online at doi:10.1016/j.str.2011.09.021.
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